非酒精性脂肪性肝病对HIV感染者生存的影响
这项在西班牙三个中心开展的前瞻性队列纳入2151例HIV感染者,中位随访7.3年,发现肝脏硬度测量值(LSM)与FAST评分≥0.67均与全因死亡及肝相关死亡风险相关,LSM与FAST评分对生存的预测能力相似(AUROC 0.812 vs 0.825,p=0.386)。
要点
- 在844例有NAFLD可能的HIV感染者中,LSM每增加1 kPa,全因死亡风险独立升高(AHR 1.06,95%CI 1.04-1.08,p<0.001)。
- FAST评分≥0.67与生存相关(AHR 1.87,95%CI 1.40-2.50,p<0.001)。
- LSM与FAST评分对生存的预测能力相似(AUROC 0.812 vs 0.825,p=0.386)。
核心结论
- 对于HIV感染者,进展期肝纤维化增加全因死亡和肝相关死亡风险,LSM与FAST评分对有NAFLD可能的HIV感染者的生存预测能力相似。
研究设计与样本
- 前瞻性队列研究,纳入西班牙三个中心随访的HIV感染者,自首次瞬时弹性成像评估之日起入组,共2151例,中位随访7.3年(Q1-Q3 3.5-10.4年)。
主要发现
- 队列共记录174例(8.1%)死亡。
- 在844例有NAFLD可能的HIV感染者中,LSM每增加1 kPa与全因死亡独立相关(AHR 1.06,95%CI 1.04-1.08,p<0.001)。
- 在另一模型中经调整后,FAST评分≥0.67与生存相关(AHR 1.87,95%CI 1.40-2.50,p<0.001)。
- 基于LSM的模型AUROC为0.812(95%CI 0.739-0.885),基于FAST的模型AUROC为0.825(95%CI 0.753-0.897),两者比较p=0.386。
关键数值与推荐
- LSM每增加1 kPa,全因死亡AHR 1.06(95%CI 1.04-1.08,p<0.001)。
- FAST评分≥0.67,全因死亡AHR 1.87(95%CI 1.40-2.50,p<0.001)。
- LSM模型AUROC 0.812(95%CI 0.739-0.885) vs FAST模型AUROC 0.825(95%CI 0.753-0.897),p=0.386。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is an increasing concern for people living with HIV (PLWH). However, information on the impact of NAFLD on the prognosis of PLWH is very scarce. AIMS: To investigate the influence of NAFLD on the overall and liver-related mortality in PLWH. METHODS: PLWH followed in three Spanish centres were included in a prospective cohort at the date of the first transient elastography evaluation. Survival data were recorded, and the causes of death were centrally monitored. The risk of all-cause death and liver-related death was evaluated by applying time-to-event analyses. RESULTS: A total of 2151 PLWH were included in the cohort and followed for a median (Q1-Q3) of 7.3 (3.5-10.4) years. There were 174 (8.1%) deaths. The probability of overall death and liver-related death was associated with liver stiffness measurement (LSM) and with FibroScan-AST (FAST) score. Among 844 PLWH with potential for NALFD, LSM was independently associated with all-cause mortality (adjusted hazard ratio [AHR], by 1 kPa increase: 1.06; 95% confidence interval [95% CI]: 1.04-1.08; p < 0.001). In a separate model and after adjustment, FAST score ≥ 0.67 was related to survival (AHR: 1.87; 95% CI: 1.40-2.50; p < 0.001). The AUROC (95% CI) of the models were based on LSM, 0.812 (0.739-0.885); and FAST, 0.825 (0.753-0.897) (p = 0.386). CONCLUSIONS: For PLWH, advanced liver fibrosis increases the risk of overall death and liver-related death. LSM and the FAST score are similar predictors of survival for PLWH with potential for NAFLD.
引用
- Macias J, Frias M, Pineda JA, et al. Impact of Nonalcoholic Fatty Liver Disease on the Survival of People Living With HIV. Aliment Pharmacol Ther. 2024. PMID: 39604811. doi:10.1111/apt.18413
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。